My research at Prinses Máxima focuses on identifying the epigenetic determinants that drive tumor plasticity and dictate the progression of a subset of tumors caused by single mutations in key epigenetic factors. To this end, I apply advanced single-cell technologies to characterize the transcriptional and epigenetic landscape of patient-derived samples and established organoid lines, with the ultimate goal of reversing the malignant state.

Outside of science, I try to stay active playing football and padel and occasionally going to the gym. In my quieter moments, I’m working—often in vain—on improving my piano skills or enjoying time with friends over a beer or two.